Project: Heart Failure Policy Summit 2024

Heart Failure Policy Summit 2024
This April, the HFPN is delighted to host the Heart Failure Policy Summit 2024.

What is the Heart Failure Policy Summit?

The Heart Failure Policy Network is thrilled to invite you to a pivotal event in heart failure advocacy – the third international Heart Failure Policy Summit.

This virtual event is the only global showcase for leaders from policy, academia, advocacy and clinical settings to work together to enhance heart failure care and policy.

The 2024 Summit will take place at an exciting time in heart failure, when advancements in research and treatment options and the advent of novel technologies are promising to reshape the landscape of heart failure care. A renewed focus on long-term sustainability in the context of healthy ageing and increased political attention on cardiovascular disease brings new political opportunities to argue the societal case for investment.

Our two sessions will showcase discussions between experts in policy and practice, and will highlight the latest national and international initiatives, with an emphasis on sustainable health system transformation.

Our goal is to provide heart failure champions from all sectors – across Europe and the world – with an inspirational, relevant and highly effective discussion to transform what our future goals must be. We will showcase the key pioneers, arguments, opportunities and political developments that every committed advocate or leader in heart failure needs to know.

Register now

When is the Summit?

The 2024 Summit will be held as two online sessions:

 

Heart failure as a top priority: the road to political commitment

Tuesday, 9 April 2024, 15.00–16.30 CET (09.00–10.30 EST)

Hear directly from policy experts to discover how heart failure can be positioned as a priority for building sustainable health systems. We will also learn how the business case for investment in heart failure is evolving and how advocates have secured government support and reimbursement for better heart failure diagnosis and care.

 

Learning from change–makers: real–world successes in heart failure

Thursday, 11 April 2024, 15.00–16.30 CET (09.00–10.30 EST)

Join our second session to hear about the latest advancements in heart failure clinical science, a renewed research horizon in heart failure, and what this all means for governments around the world. We will also hear from leading heart failure advocates working at national or international level and gain insight into how they are transforming patient outcomes and changing delivery models in real-world settings.

The Summit is designed to be interactive, with participants having the opportunity to engage with speakers through Q&A sessions and offer input through interactive polling questions.

 

Register now

Project advisory group

Mr Marc Bains
Co-founder, HeartLife Foundation & Co-Lead, Canadian Heart Function Alliance
Dr Antoni Bayes Genis
Head of the Cardiology Department, University Hospital Germans Trias i Pujol
Professor Salvatore Di Somma
Professor of Medicine, University La Sapienza Rome, & Director of Scientific Board, Associazione Italiana Scompensati Cardiaci - AISC
Dr Luis Filipe Pereira
President, Associação de Apoio aos Doentes com Insuficiência Cardíaca (AADIC)
Professor Damien Gruson
Head of Department of Laboratory Medicine and Head of Clinical Biochemistry, Cliniques Universitaires Saint-Luc
Ms Penilla Gunther
Founder, FOKUS Patient
Mr Nick Hartshorne-Evans
CEO, Pumping Marvellous Foundation
Professor Ekaterini Lambrinou
Dean of the School of Health Sciences, Cyprus University of Technology
Mr Rodolfo Pike
Executive Committee member, Canadian Heart Failure Society
Ms Aistė Štaraitė
President, Lithuanian Heart Failure Association

Sponsors

The HFPN Secretariat would like to thank the following sponsors for supporting the Summit:

  • AstraZeneca
  • Roche Diagnostics

 

The 2024 Heart Failure Policy Summit is sponsored by AstraZeneca and Roche Diagnostics. Full editorial control of agenda development, all Summit materials and sessions (including speaker management) lies with the HFPN Secretariat, guided by the Steering Committee and Summit Project Advisory Group. Sponsors have provided input to the Summit’s agenda, which was developed by the HFPN Secretariat.

Related Articles

The Heart Failure Policy Summit returns in April 2024 to bring together heart failure advocates from across the world
News
The Heart Failure Policy Summit returns in April 2024 to bring together heart failure advocates from across the world
18th January 2024
This April, the HFPN is delighted to host the Heart Failure Policy Summit 2024.
Read article
Mental health in heart failure put under the spotlight in new call to action
News
Mental health in heart failure put under the spotlight in new call to action
20th July 2023
The HFPN published a new call to action to raise awareness of the relationship between heart failure and mental health, and drive change for this issue at EU level.
Read article
New briefing provides heart failure advocates with actionable ways to improve access to best-practice care in Germany
News
New briefing provides heart failure advocates with actionable ways to improve access to best-practice care in Germany
15th May 2023
The final advocacy briefing in our From guidelines to action series highlights the opportunities for heart failure advocates to improve care in Germany.
Read article
Tackling the overlooked epidemic of heart failure in Germany
Blog
Tackling the overlooked epidemic of heart failure in Germany
4th May 2023
Heart failure is prevalent in Germany, but is under-recognised. Key stakeholders came together at the German Heart Failure Roundtable to discuss the need for policy change and comp
Read article
It is time to put quality of life at the centre of heart failure care
Blog
It is time to put quality of life at the centre of heart failure care
15th November 2022
More than 90% of people with heart failure would like regular discussion about quality of life to be part of their care, but this only happens for 20%.
Read article
The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from AstraZeneca and Roche Diagnostics. The content produced by the Network is not biased toward any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members. All members provide their time for free. The Network is hosted by The Health Policy Partnership .